icad inc. (ICAD): Price and Financial Metrics
ICAD Price/Volume Stats
Current price | $1.30 | 52-week high | $4.66 |
Prev. close | $1.28 | 52-week low | $1.05 |
Day low | $1.28 | Volume | 72,100 |
Day high | $1.34 | Avg. volume | 152,355 |
50-day MA | $1.34 | Dividend yield | N/A |
200-day MA | $1.97 | Market Cap | 33.08M |
ICAD Stock Price Chart Interactive Chart >
ICAD POWR Grades
- ICAD scores best on the Value dimension, with a Value rank ahead of 74.49% of US stocks.
- ICAD's strongest trending metric is Stability; it's been moving down over the last 179 days.
- ICAD ranks lowest in Momentum; there it ranks in the 15th percentile.
ICAD Stock Summary
- With a market capitalization of $34,098,185, ICAD INC has a greater market value than only 11.72% of US stocks.
- With a year-over-year growth in debt of 240.91%, ICAD INC's debt growth rate surpasses 94.11% of about US stocks.
- Revenue growth over the past 12 months for ICAD INC comes in at -19.43%, a number that bests only 11.61% of the US stocks we're tracking.
- Stocks that are quantitatively similar to ICAD, based on their financial statements, market capitalization, and price volatility, are SHPW, KRKR, FARO, TACT, and BKYI.
- Visit ICAD's SEC page to see the company's official filings. To visit the company's web site, go to www.icadmed.com.
ICAD Valuation Summary
- In comparison to the median Technology stock, ICAD's price/sales ratio is 46.94% lower, now standing at 1.3.
- ICAD's price/sales ratio has moved down 5.7 over the prior 243 months.
Below are key valuation metrics over time for ICAD.
Stock | Date | P/S | P/B | P/E | EV/EBIT |
---|---|---|---|---|---|
ICAD | 2023-05-22 | 1.3 | 1.1 | -2.4 | -1.2 |
ICAD | 2023-05-19 | 1.3 | 1.1 | -2.5 | -1.3 |
ICAD | 2023-05-18 | 1.2 | 1.0 | -2.3 | -1.1 |
ICAD | 2023-05-17 | 1.2 | 1.0 | -2.2 | -1.0 |
ICAD | 2023-05-16 | 1.1 | 0.9 | -2.1 | -0.9 |
ICAD | 2023-05-15 | 1.2 | 1.0 | -2.3 | -1.1 |
ICAD Growth Metrics
- The year over year price growth rate now stands at -81.39%.
- Its 5 year net cashflow from operations growth rate is now at -29.84%.
- Its 3 year net income to common stockholders growth rate is now at -39.08%.

The table below shows ICAD's growth in key financial areas (numbers in millions of US dollars).
Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
---|---|---|---|
2022-09-30 | 29.262 | -11.207 | -14.707 |
2022-06-30 | 32.267 | -10.84 | -12.985 |
2022-03-31 | 32.518 | -10.294 | -13.147 |
2021-12-31 | 33.638 | -9.408 | -11.245 |
2021-09-30 | 36.282 | -8.763 | -8.702 |
2021-06-30 | 34.05 | -8.989 | -8.323 |
ICAD's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- ICAD has a Quality Grade of C, ranking ahead of 38.2% of graded US stocks.
- ICAD's asset turnover comes in at 0.555 -- ranking 80th of 186 Medical Equipment stocks.
- TTOO, IRMD, and DYNT are the stocks whose asset turnover ratios are most correlated with ICAD.
The table below shows ICAD's key quality metrics over time.
Period | Asset Turnover | Gross Margin | ROIC |
---|---|---|---|
2021-06-30 | 0.555 | 0.714 | -0.737 |
2021-03-31 | 0.561 | 0.728 | -0.590 |
2020-12-31 | 0.628 | 0.719 | -1.587 |
2020-09-30 | 0.653 | 0.736 | -1.431 |
2020-06-30 | 0.695 | 0.752 | -1.339 |
2020-03-31 | 0.769 | 0.754 | -1.337 |
ICAD Price Target
For more insight on analysts targets of ICAD, see our ICAD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
Average Price Target | $24.00 | Average Broker Recommendation | 1.31 (Strong Buy) |
icad inc. (ICAD) Company Bio
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer in the United States and internationally. It operates through two segments, Cancer Detection and Cancer Therapy. The company was founded in 1984 and is based in Nashua, New Hampshire.
Latest ICAD News From Around the Web
Below are the latest news stories about ICAD INC that investors may wish to consider to help them evaluate ICAD as an investment opportunity.
3 High-Reward Stocks Riding the AI BoomAI will make many companies' businesses much more effective and profitable, so the best AI stocks are very attractive. |
iCAD’s ProFound AI Breast Suite Wins U.S. General Services Administration’s AI Healthcare Challenge AwardCompany presented portfolio of breast cancer detection, density assessment and risk evaluation solutions at the competition, focused on improving health outcomesNASHUA, N.H., May 18, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced its ProFound AI® Breast Suite is a winner of the U.S. General Services Administration’s (GSA) “AI Healthcare Challenge” award. iCAD presented its portfol |
iCAD, Inc. (ICAD) Q1 2023 Earnings Call TranscriptiCAD, Inc. (ICAD) Q1 2023 Earnings Conference Call May 15, 2023, 04:30 PM ET Company Participants Linnell Faber - Executive Assistant to CEO Dana Brown - President and CEO Eric Lonnqvist - CFO Conference Call Participants Per Ostlund - Craig Hallum Marie Thibault - BTIG Yale Jen - Laidlaw & Company Frank Takkinen - Lake Street Capital Markets Francois Brisebois - Oppenheimer Presentation Operator Good day, everyone, and welcome to the iCAD, Inc. First Quarter 2023 Earnings Call. At this time all participants have been placed on a listen-only mode and we will open the floor for your questions and comments after the presentati... |
Q1 2023 ICAD Inc Earnings CallQ1 2023 ICAD Inc Earnings Call |
iCAD Non-GAAP EPS of -$0.14 misses by $0.03, revenue of $5.77M misses by $0.44M
|
ICAD Price Returns
1-mo | -7.14% |
3-mo | -52.03% |
6-mo | -28.57% |
1-year | -65.97% |
3-year | -88.93% |
5-year | -61.88% |
YTD | -28.96% |
2022 | -74.58% |
2021 | -45.45% |
2020 | 69.88% |
2019 | 110.00% |
2018 | 7.56% |
Continue Researching ICAD
Want to do more research on Icad Inc's stock and its price? Try the links below:Icad Inc (ICAD) Stock Price | Nasdaq
Icad Inc (ICAD) Stock Quote, History and News - Yahoo Finance
Icad Inc (ICAD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...